X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ACTAVIS (US) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ACTAVIS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ACTAVIS
Dec-14
STERLING BIOTECH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1119,451-   
Low Rs311,864-   
Sales per share (Unadj.) Rs26.83,502.5-  
Earnings per share (Unadj.) Rs-15.0-437.1-  
Cash flow per share (Unadj.) Rs-5.5321.3-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.97,596.8-  
Shares outstanding (eoy) m267.87265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.5 5.8%   
Avg P/E ratio x-0.5-35.8 1.3%  
P/CF ratio (eoy) x-1.348.7 -2.6%  
Price / Book Value ratio x0.12.1 6.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8624,163,324 0.0%   
No. of employees `0001.421.6 6.3%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.343,116.7 12.3%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.0-5,380.5 55.0%   
INCOME DATA
Net Sales Rs m7,181931,321 0.8%  
Other income Rs m43-2,324 -1.8%   
Total revenues Rs m7,223928,996 0.8%   
Gross profit Rs m947119,641 0.8%  
Depreciation Rs m2,543201,665 1.3%   
Interest Rs m4,37729,376 14.9%   
Profit before tax Rs m-5,931-113,724 5.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-8,342 0.0%   
Tax Rs m-1,924-5,847 32.9%   
Profit after tax Rs m-4,007-116,219 3.4%  
Gross profit margin %13.212.8 102.6%  
Effective tax rate %32.45.1 631.1%   
Net profit margin %-55.8-12.5 447.1%  
BALANCE SHEET DATA
Current assets Rs m14,335490,687 2.9%   
Current liabilities Rs m49,809357,855 13.9%   
Net working cap to sales %-494.014.3 -3,463.7%  
Current ratio x0.31.4 21.0%  
Inventory Days Days40358 695.3%  
Debtors Days Days17166 257.4%  
Net fixed assets Rs m55,432113,724 48.7%   
Share capital Rs m2680-   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7012,020,000 0.7%   
Long term debt Rs m9,4781,058,520 0.9%   
Total assets Rs m73,9883,701,996 2.0%  
Interest coverage x-0.4-2.9 12.4%   
Debt to equity ratio x0.60.5 123.0%  
Sales to assets ratio x0.10.3 38.6%   
Return on assets %0.5-2.3 -21.4%  
Return on equity %-27.3-5.8 473.7%  
Return on capital %-6.4-3.0 213.4%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719159,926 1.1%  
From Investments Rs m-3,148-382,924 0.8%  
From Financial Activity Rs m1,426215,148 0.7%  
Net Cashflow Rs m-3-7,850 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.3 Rs / USD

Compare STERLING BIOTECH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: SUN PHARMA  NOVARTIS  SANOFI INDIA  STRIDES PHARMA SCIENCE  VENUS REMEDIES  



Today's Market

Sensex Ends 274 Points Lower; IT and Energy Stocks Witness Selling(Closing)

Share markets in India continued to witness selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS